Capricor Therapeutics
A Senior Director of Quality at Capricor Therapeutics leads the design and execution of the Quality Management System (QMS) to ensure regulatory compliance and quality oversight across clinical, manufacturing, and commercial operations. The role involves strategic leadership, cross-functional collaboration, and continuous improvement to support late-stage development, BLA submissions, and commercial readiness.
Headquarters
San Diego, California, United States
Company Size
51-200 employees
Founded
2005
Capricor Therapeutics, Inc. (NASDAQ: CAPR) is a San Diego–based biotechnology company developing cell- and exosome-based therapeutics for muscular and other select diseases. Its lead candidate, deramiocel (CAP‑1002), is an allogeneic cell therapy currently in Phase 3 clinical development for Duchenne muscular dystrophy. Capricor is also advancing exosome technology as a next‑generation platform, engineering exosomes to deliver nucleic acids and proteins to treat or prevent a variety of diseases. The company focuses on translating these platforms into novel therapeutic and preventive products.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Capricor Therapeutics.
Right around the average for this role
Duchenne trial drug from Capricor slows key task decline 83%
23 hours ago
Associate Director, Quality Control
Beam Therapeutics
Manager, Quality Assurance
Celldex Therapeutics
Senior Director, Quality
Maze Therapeutics
Manager, Quality Management Systems & Validations
Ocular Therapeutix
Associate Director, GMP Quality Assurance
Revolution Medicines
Senior Manager, GMP Quality
Revolution Medicines